A new study led by Chinese university scientists has identified a compound derived from the antiviral drug remdesivir that exhibits potential as an oral treatment for COVID-19.
Published in the journal Science Translational Medicine, the study shows that ATV006, which was synthesized from the remdesivir derivative GS-441524, demonstrated improved oral absorption and robust antiviral efficacy against SARS-CoV-2 and variants in animal tests.
According to…